AxoGen investor relations material

Listen to the latest call from AxoGen

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for peripheral nerve injury. It provides Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector that is a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector that is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. The company also offers Avive Soft Tissue Membrane that is a processed human umbilical cord membrane used as a resorbable barrier to separate tissues in repair or reconstruction procedures; and AcroVal Neurosensory & Motor Testing System.

  • Ticker

  • Country


Dig deeper into the AxoGen fundamentals on Quartr.